Clinical Trials Browser

EGFR-mutant Non-small Cell Lung Cancer × nazartinib × 90 days × Clear all

NCT03333343 2026-01-16

Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC

Phase 1 Active not recruiting

EGFR-mutant Non-small Cell Lung Cancer